Visitor restrictions and mask requirements are still in place at all Scripps facilities. If you suspect you have COVID, please visit MyScripps first and answer the COVID-19 Symptom Checker questions. 

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Union-Tribune Reports Experimental Diabetes Drug Shows Promise

Athena Philis-Tsimikas, MD, comments on early mouse study

A Scripps doctor talks about an experimental diabetes drug with a Type 2 diabetes patient.

Athena Philis-Tsimikas, MD, comments on early mouse study

An experimental drug tested in mice shows potential for improving blood sugar control with type 2 diabetes, said Scripps diabetes expert Athena Philis-Tsimikas, MD, in a recent San Diego Union-Tribune report.

"The mechanisms for these new agents look promising, and it is encouraging that the science is progressing especially here in San Diego," said Dr. Tsimikas, who is corporate vice president of Scripps Whittier Diabetes Institute.

Read the Union-Tribune report: Type 2 Diabetes Reversed With New Drug in Mouse Study

Media Contact

Keith Darce